News
Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.
In July 2025, Regeneron Pharmaceuticals organized a study is researching an experimental drug called REGN5381 (called "study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback